These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

252 related items for PubMed ID: 16423207

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer.
    Lee BE, von Haag D, Lown T, Lau D, Calhoun R, Follette D.
    J Thorac Cardiovasc Surg; 2007 Mar; 133(3):746-52. PubMed ID: 17320577
    [Abstract] [Full Text] [Related]

  • 7. Accuracy of FDG PET/CT in the evaluation of solitary pulmonary lesions - own experience.
    Opoka L, Kunikowska J, Podgajny Z, Szołkowska M, Błasińska-Przerwa K, Burakowska B, Oniszh K, Rudziński P, Bestry I, Roszkowski-Śliż K.
    Pneumonol Alergol Pol; 2014 Mar; 82(3):198-205. PubMed ID: 24793147
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Mediastinal lymph node staging by means of positron emission tomography is less sensitive in elderly patients with non-small-cell lung cancer.
    Al-Sarraf N, Gately K, Lucey J, Wilson L, McGovern E, Young V.
    Clin Lung Cancer; 2008 Jan; 9(1):39-43. PubMed ID: 18282357
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Impact of PET/CT on precise radiotherapy planning for non-small cell lung cancer].
    Gong HY, Yu JM, Fu Z, Li BS, Li JB, Liu TH.
    Zhonghua Zhong Liu Za Zhi; 2006 Jan; 28(1):54-7. PubMed ID: 16737623
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Prevalence of occult metastatic disease in patients undergoing 18F-FDG PET for primary diagnosis or staging of lung carcinoma and solitary pulmonary nodules.
    Lee ST, Berlangieri SU, Poon AM, Mitchell P, Pathmaraj K, Tabone K, Byrne AJ, O'Keefe GJ, Knight SR, Clarke CP, Scott AM.
    Intern Med J; 2007 Nov; 37(11):753-9. PubMed ID: 17517082
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Does positron emission tomography prevent nontherapeutic pulmonary resections for clinical stage IA lung cancer?
    Kozower BD, Meyers BF, Reed CE, Jones DR, Decker PA, Putnam JB.
    Ann Thorac Surg; 2008 Apr; 85(4):1166-9; discussion 1169-70. PubMed ID: 18355490
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high.
    Turkmen C, Sonmezoglu K, Toker A, Yilmazbayhan D, Dilege S, Halac M, Erelel M, Ece T, Mudun A.
    Clin Nucl Med; 2007 Aug; 32(8):607-12. PubMed ID: 17667432
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.